Research & Education

CEO Statement - IASLC Applauds US Pharmacy’s Decision to Stop Selling Tobacco Products

February 5, 2014

Contact: Kristin Richeimer

IASLC Director of Membership

Kristin.richeimer@iaslc.org

(720) 325-2953

Aurora, CO – CVS Caremark, a US-based pharmacy chain, announced Wednesday it will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores by October 1.  In doing so, the company will be the first chain of pharmacies in the USA to discontinue tobacco sales. As the largest pharmacy in the United States based on total prescription revenue, according to the company, this represents a bold--and hopefully trendsetting--move.  

The International Association for the Study of Lung Cancer (IASLC) is the only global organization solely dedicated to conquering lung cancer. Tobacco use is the leading preventable cause of death in the U.S. and worldwide, causing 6.3 million deaths a year. In addition, cigarette smoking is responsible for about one in five deaths annually and a major contributor to the global pandemic of tobacco-related diseases.  This announcement follows a January 17, 2013 report from the US Surgeon General on the 50th Anniversary of the landmark 1964 first Surgeon General report on smoking and health.

The IASLC applauds this move by CVS Caremark, and strongly encourages other retailers around the world to follow suit and immediately discontinue the sale of tobacco products.  CVS Caremark has recognized and stated that “Cigarettes and tobacco products have no place in a setting where health care is delivered. This is the right thing to do.” IASLC couldn’t agree more.

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association’s membership includes more than 3,800 lung cancer specialists in 80 countries. To learn more about IASLC please visit www.iaslc.org.